Products

Rafenthic

Marketing that compounds, not just clicks.

rafenthic.com Software Development / Software Development Services

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Sep 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Abdullah Abid
@rafenthic· 3 followers
Launched
7mo ago
2026-04-22 · Est.

Traffic

Last 12 months
Monthly visitsData through Sep 2026 · Oct 2026 pending
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@rafenthic@rafenthic

  • Launched on Product HuntLaunch

    where businesses become brands

    Apr 22 · 7mo agoLaunch page

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Direct37%
  • Organic Search30%
  • Social9%
  • Referrals8%
  • Other16%

Countries

  • Pakistan78%
  • India22%

Search

Domain authority —Domain registered 2025-05-23

KeywordMonthly volume
"marketing agency" and ("write for us" or "submit an article")120
abdullah abid personal brand seo50
peronal brand seo30
muhammad hasnain seo anlayst20
personal brand sseo20

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-03 · Source page

Pages & changes

Tracked since 2026-04-22

Key pages

Weekly snapshots
www.rafenthic.com/ Snapshot 2026-11-04

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Rafenthic get?
Vaneform estimates <5K website visits in 2026-09. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Rafenthic and what platforms does it support?
Rafenthic is catalogued under Software Development Services: Marketing that compounds, not just clicks.. Supported platforms: Web.

Related products in this category

Software Development / Software Development Services

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.